Name: Pathogenesis and Novel Therapeutics in Asthma (en Inglés)
SKU: 57900008
Price: 69.13 USD
Availability: InStock
Author: Bazan-Socha, Stanislawa

portada Pathogenesis and Novel Therapeutics in Asthma (en Inglés)

Pathogenesis and Novel Therapeutics in Asthma (en Inglés)

Formato

Libro Físico

Editorial

Mdpi AG

Autor

Bazan-Socha, Stanislawa

Idioma

Inglés

N° páginas

168

Encuadernación

Tapa Dura

Dimensiones

24.4x17x1.6 cm

Peso

0.57 kg.

ISBN13

9783036578422

Categorías

Farmacología

Pathogenesis and Novel Therapeutics in Asthma (en Inglés)

Bazan-Socha, Stanislawa (Autor) · Mdpi AG · Tapa Dura

Libro Nuevo Importado

Envío: 21 a 28 días háb.

$ 138.26$ 69.13

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 69.13

Llega entre el 25 Sep y el 08 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Pathogenesis and Novel Therapeutics in Asthma (en Inglés)"

Asthma is a prevalent chronic inflammatory disease of the airways with complex etiology and mechanistic pathways and variable clinical presentation. Such heterogeneity renders the search for targeted therapies difficult. Currently, the best-known disease phenotype with tailored biological treatment is eosinophilic asthma; however, even in some of these patients, anti-IL5 treatment is ineffective. Furthermore, about a quarter of patients, especially those with a severe phenotype, develop progressive and irreversible airway obstruction, leading to persistent symptoms despite optimized treatment. Therefore, new therapeutic approaches are still needed, particularly in severe asthma. The Special Issue presents asthma research focusing on modern personalized therapeutic approaches. Particular interest is directed to novel asthma biomarkers, including molecular and epigenetic ones, shining new light on pathogenesis, phenotyping, and customized therapy in various airway inflammatory patterns of the disease. In addition, research articles on airway epithelial cell dysfunction, airway remodeling, and the overlap between asthma and chronic obstructive pulmonary disease are welcomed.Stanislawa Bazan-Socha (Guest Editors)